IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Associations of leptin levels with psychopathology, BDNF and inflammatory cytokines in patients with chronic schizophrenia as well as gender differences
- Zhao L. , et al.
2. Serum S100B is related to insulin resistance and zinc-α2-glycoprotein levels in patients with chronic schizophrenia
- Kalejahi P. , et al.
3. Hyperleptinemia contributes to antipsychotic drug–associated obesity and metabolic disorders
- Zhao S. , et al.
4. Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review
- Kozlowski T. , et al.
5. Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients
- Morera-Fumero A.L. , et al.
8. Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia
- Mackey M. , et al.
9. Medical comorbidity among psychiatric patients treated at Jimma University Medical Center, Southwest Ethiopia: Retrospective record review
- Teshome M. , et al.
10. Different serum protein factor levels in first-episode drug-naive patients with schizophrenia characterized by positive and negative symptoms
- Dai N. , et al.
11. Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies
- Futtrup J. , et al.
13. Day/night changes in serum S100B protein concentrations in acute paranoid schizophrenia
- Morera-Fumero A. , et al.